Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.38 |
| ▸ | PTGER3 | P43115 | 9/20 | 0.38 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5675467 | 1.00 | HRH3 (0.38) | HRH3PTGER3BCL2L1MCL1PPARG | |
| SCHEMBL5672601 | 0.95 | PPARG (0.41) | HRH3PTGER3BCL2L1MCL1PPARG | |
| SCHEMBL5672598 | 0.95 | PPARG (0.41) | HRH3PTGER3BCL2L1MCL1PPARG | |
| SCHEMBL5673719 | 0.88 | S1PR1 (0.43) | PTGER3BCL2L1MCL1 | |
| SCHEMBL5673725 | 0.88 | S1PR1 (0.43) | PTGER3BCL2L1MCL1 | |
| SCHEMBL5672537 | 0.87 | BCL2L1 (0.43) | HRH3PTGER3BCL2L1MCL1 | |
| SCHEMBL5672531 | 0.87 | BCL2L1 (0.43) | HRH3PTGER3BCL2L1MCL1 | |
| SCHEMBL5672933 | 0.86 | BCL2L1 (0.44) | HRH3PTGER3BCL2L1MCL1 | |
| SCHEMBL5672936 | 0.86 | BCL2L1 (0.44) | HRH3PTGER3BCL2L1MCL1 | |
| SCHEMBL5672638 | 0.85 | PTGES (0.41) | PTGER3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7060721-B1 | Imidazole compounds and medicinal use thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2006-06-13 | — | — | US | disclosed |
| EP-1142879-A1 | IMIDAZOLE COMPOUNDS AND MEDICINAL USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-10-10 | — | — | EP | disclosed |